Literature DB >> 33925397

Velocity Gradient Separation Reveals a New Extracellular Vesicle Population Enriched in miR-155 and Mitochondrial DNA.

Myriam Vaillancourt1, Audrey Hubert1, Caroline Subra1,2,3, Julien Boucher1, Wilfried Wenceslas Bazié1,4, Julien Vitry1, Sofiane Berrazouane1, Jean-Pierre Routy5,6, Sylvie Trottier1,7, Cécile Tremblay8,9, Mohammad-Ali Jenabian10, Abderrahim Benmoussa1,11, Patrick Provost1,7, Philippe A Tessier1,7, Caroline Gilbert1,7.   

Abstract

Extracellular vesicles (EVs) and their contents (proteins, lipids, messenger RNA, microRNA, and DNA) are viewed as intercellular signals, cell-transforming agents, and shelters for viruses that allow both diagnostic and therapeutic interventions. EVs circulating in the blood of individuals infected with human immunodeficiency virus (HIV-1) may provide insights into pathogenesis, inflammation, and disease progression. However, distinguishing plasma membrane EVs from exosomes, exomeres, apoptotic bodies, virions, and contaminating proteins remains challenging. We aimed at comparing sucrose and iodixanol density and velocity gradients along with commercial kits as a means of separating EVs from HIV particles and contaminating protein like calprotectin; and thereby evaluating the suitability of current plasma EVs analysis techniques for identifying new biomarkers of HIV-1 immune activation. Multiple analysis have been performed on HIV-1 infected cell lines, plasma from HIV-1 patients, or plasma from HIV-negative individuals spiked with HIV-1. Commercial kits, the differential centrifugation and density or velocity gradients to precipitate and separate HIV, EVs, and proteins such as calprotectin, have been used. EVs, virions, and contaminating proteins were characterized using Western blot, ELISA, RT-PCR, hydrodynamic size measurement, and enzymatic assay. Conversely to iodixanol density or velocity gradient, protein and virions co-sedimented in the same fractions of the sucrose density gradient than AChE-positive EVs. Iodixanol velocity gradient provided the optimal separation of EVs from viruses and free proteins in culture supernatants and plasma samples from a person living with HIV (PLWH) or a control and revealed a new population of large EVs enriched in microRNA miR-155 and mitochondrial DNA. Although EVs and their contents provide helpful information about several key events in HIV-1 pathogenesis, their purification and extensive characterization by velocity gradient must be investigated thoroughly before further use as biomarkers. By revealing a new population of EVs enriched in miR-155 and mitochondrial DNA, this study paves a way to increase our understanding of HIV-1 pathogenesis.

Entities:  

Keywords:  HIV; biomarker; calprotectin; extracellular vesicles; miR-155; miR-223; miR-92; mtDNA; velocity gradient; virions

Year:  2021        PMID: 33925397     DOI: 10.3390/pathogens10050526

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  63 in total

1.  Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes.

Authors:  Bow J Tauro; David W Greening; Rommel A Mathias; Hong Ji; Suresh Mathivanan; Andrew M Scott; Richard J Simpson
Journal:  Methods       Date:  2012-01-21       Impact factor: 3.608

2.  The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity.

Authors:  R Cantin; J F Fortin; G Lamontagne; M Tremblay
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  Sequences within RNA coding for HIV-1 Gag p17 are efficiently targeted to exosomes.

Authors:  Sandra Columba Cabezas; Maurizio Federico
Journal:  Cell Microbiol       Date:  2012-11-07       Impact factor: 3.715

4.  Isolation of biologically-active exosomes from human plasma.

Authors:  Laurent Muller; Chang-Sook Hong; Donna B Stolz; Simon C Watkins; Theresa L Whiteside
Journal:  J Immunol Methods       Date:  2014-06-18       Impact factor: 2.303

5.  Discrimination between exosomes and HIV-1: purification of both vesicles from cell-free supernatants.

Authors:  Réjean Cantin; Juliette Diou; Dave Bélanger; Alexandre M Tremblay; Caroline Gilbert
Journal:  J Immunol Methods       Date:  2008-07-31       Impact factor: 2.303

6.  Exosomes from human immunodeficiency virus type 1 (HIV-1)-infected cells license quiescent CD4+ T lymphocytes to replicate HIV-1 through a Nef- and ADAM17-dependent mechanism.

Authors:  Claudia Arenaccio; Chiara Chiozzini; Sandra Columba-Cabezas; Francesco Manfredi; Elisabetta Affabris; Andreas Baur; Maurizio Federico
Journal:  J Virol       Date:  2014-07-23       Impact factor: 5.103

7.  HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells.

Authors:  Metka Lenassi; Gerard Cagney; Maofu Liao; Tomaz Vaupotic; Koen Bartholomeeusen; Yifan Cheng; Nevan J Krogan; Ana Plemenitas; B Matija Peterlin
Journal:  Traffic       Date:  2010-01       Impact factor: 6.215

8.  Importance of exosome depletion protocols to eliminate functional and RNA-containing extracellular vesicles from fetal bovine serum.

Authors:  Ganesh Vilas Shelke; Cecilia Lässer; Yong Song Gho; Jan Lötvall
Journal:  J Extracell Vesicles       Date:  2014-09-30

9.  Transfer of Functional Cargo in Exomeres.

Authors:  Qin Zhang; James N Higginbotham; Dennis K Jeppesen; Yu-Ping Yang; Wei Li; Eliot T McKinley; Ramona Graves-Deal; Jie Ping; Colleen M Britain; Kaitlyn A Dorsett; Celine L Hartman; David A Ford; Ryan M Allen; Kasey C Vickers; Qi Liu; Jeffrey L Franklin; Susan L Bellis; Robert J Coffey
Journal:  Cell Rep       Date:  2019-04-04       Impact factor: 9.423

Review 10.  The Ambiguous Roles of Extracellular Vesicles in HIV Replication and Pathogenesis.

Authors:  Marcos V S Dias; Cristina S Costa; Luis L P daSilva
Journal:  Front Microbiol       Date:  2018-10-10       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.